A Review of the Risk Factors and Management of Refractory Hypertension: The Role of Carotid Sinus Stimulation and Renal Nerve Denervation
- PMID: 39391106
- PMCID: PMC11464058
- DOI: 10.55729/2000-9666.1364
A Review of the Risk Factors and Management of Refractory Hypertension: The Role of Carotid Sinus Stimulation and Renal Nerve Denervation
Abstract
Hypertension (HTN) is a significant health concern, with a recent increase in HTN-related cardiovascular deaths in the United States. Refractory hypertension, a form of treatment-resistant HTN, poses a challenge for physicians and patients due to its association with increased morbidity and mortality. Risk factors for refractory HTN include African ancestry, female gender, younger age, diabetes mellitus, obesity, obstructive sleep apnea, chronic kidney disease, end-stage renal disease, and smoking. While the exact pathophysiology of refractory HTN is not fully understood, sympathetic overdrive appears to be a significant contributing factor. Arterial stiffness, chronic kidney disease, obstructive sleep apnea, obesity, and diabetes mellitus are comorbid conditions associated with increased sympathetic activity and refractory HTN. The knowledge behind carotid sinus stimulation suggested promising outcomes due to the known physiology. However, the introduction of devices, surgical complications, and the development of new antihypertensive soon took over the innovation of these devices. The authors aim to highlight three important aspects related to refractory hypertension: the risk factors for the development of refractory hypertension, the role of surgery in managing hypertension, and the referral systems available for the management of refractory hypertension.
Keywords: Carotid sinus stimulation; Hypertension; Hypertension treatment; Nerve ablation; Renal nerve denervation; Resistant; Resistant hypertension; Treatment resistant hypertension.
© 2024 Greater Baltimore Medical Center.
Conflict of interest statement
Conflict of interest: There is no conflict of interest.
Similar articles
-
Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.Curr Hypertens Rep. 2018 Sep 7;20(11):92. doi: 10.1007/s11906-018-0893-8. Curr Hypertens Rep. 2018. PMID: 30194545 Review.
-
Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.Curr Hypertens Rep. 2017 Feb;19(2):18. doi: 10.1007/s11906-017-0713-6. Curr Hypertens Rep. 2017. PMID: 28243928 Review.
-
Resistant hypertension in 2017.Curr Opin Cardiol. 2017 Jul;32(4):389-396. doi: 10.1097/HCO.0000000000000412. Curr Opin Cardiol. 2017. PMID: 28505045 Review.
-
Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.Hypertension. 2011 Oct;58(4):559-65. doi: 10.1161/HYPERTENSIONAHA.111.173799. Epub 2011 Aug 15. Hypertension. 2011. PMID: 21844482 Clinical Trial.
-
[Renal denervation: current state and future perspectives].Herz. 2012 Nov;37(7):746-53. doi: 10.1007/s00059-012-3689-7. Herz. 2012. PMID: 23073661 German.
References
-
- Facts about Hypertension [Internet] Centers for Disease Control and Prevention; 2023. https://www.cdc.gov/bloodpressure/facts.htm .
-
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of High blood pressure in adults. J Am Coll Cardiol. 2018;71:127–248. - PubMed
-
- Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American heart association professional education committee of the Council for High blood pressure Research. Hypertension. 2008;51:1403–1419. doi: 10.1161/HYPERTENSIONAHA.108.189141. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources